A Scant Prenatal Pap With One Abnormal Cluster
A 31-year-old G2P1 at 14 weeks' gestation has a liquid-based Pap at her first prenatal visit. The vial yields a thin, partially air-dried slide with an estimated 2,000 well-visualized squamous cells. There is a single 12-cell cluster of squamous cells with nuclei roughly three times the size of a mature intermediate cell nucleus, slightly irregular nuclear membranes, and finely granular chromatin. No koilocytic halos, no dyskeratosis, and no endocervical or metaplastic cells are seen. Her last Pap, three years ago, was negative; HPV history is unknown. The requisition reads 'pregnant - abnormalities? please advise.' The laboratory's standing protocol is reflex HPV testing on residual vial material for ASC-US.
1. Do you sign this out as unsatisfactory, negative, or ASC-US? Defend the choice using adequacy principles rather than a cell count alone.
Read the worked answer
Decision: ASC-US. Do not call it unsatisfactory, and do not call it negative.
Reasoning:
- Adequacy exists to protect against false negatives, not to suppress true positives. The purpose of a cellularity benchmark (roughly 5,000 well-visualized squamous cells for liquid-based preparations, 8,000-12,000 for conventional smears) is to flag slides where a lesion could be missed. Here an interpretable abnormality is present, so the specimen is by definition satisfactory for evaluation.
- Report the abnormality with a limitation qualifier. About 2,000 cells is below the benchmark, so append a comment such as 'satisfactory for evaluation but limited by low squamous cellularity' rather than 'unsatisfactory.' Reserve unsatisfactory for slides that cannot be interpreted (obscuring blood, air-drying, too few cells with no abnormality).
- Why ASC-US and not LSIL or negative. Nuclear enlargement of about three diameters with irregular membranes exceeds reactive change, but there are no koilocytic halos and the atypia is confined to one small group, so the threshold for LSIL is not met. Downgrading to negative would be a false negative; upgrading to LSIL would overcall a single cluster.
- Absent transformation zone component is not a reason for unsatisfactory. It is common in pregnancy and is reported as a note only.
2. Reflex HPV is ordered. Walk through the management of each possible HPV result for this pregnant patient, and state what you would do if the residual material were exhausted.
Read the worked answer
The patient is 31, so she follows the age 25-and-over pathways; pregnancy changes what procedures are done, not which triage algorithm applies.
- HPV negative: repeat HPV-based testing (co-test or primary HPV) in 3 years. Not one year, and not colposcopy. Schedule it for the postpartum visit for convenience.
- HPV positive, non-16/18: colposcopy. Pregnancy is not a contraindication to colposcopy; however, endocervical curettage, endometrial sampling, and any excisional treatment are deferred until after delivery, and biopsy is taken only if a high-grade lesion or cancer is suspected.
- HPV 16 or 18 positive: colposcopy, same caveats. Do not perform ECC or a cone in the pregnant patient.
- Residual material exhausted / HPV not performed: do not leave the patient unscheduled. Either repeat an HPV-based test in about one year or proceed to colposcopy; both are defensible, and the essential step is documenting a defined plan and follow-up. A repeat Pap within a few weeks would not change management and risks a second poor-quality sample.
3. The clinician calls and asks whether the Pap should be repeated next week 'to be sure.' What do you advise, and what would you document in the report?
Read the worked answer
Advise against an immediate repeat.
- Repeat cytology at a short interval does not shorten the time to a diagnosis, does not change the reflex HPV result, and in a pregnant patient with a scant slide increases the chance of a second unsatisfactory specimen, which stalls management further.
- The reflex HPV result is the branch point; a repeat Pap adds cost and anxiety without altering the decision tree.
- Exception: if HPV cannot be performed and the clinician prefers surveillance over colposcopy, a repeat HPV-based test at roughly one year (or colposcopy) is appropriate - not a repeat in one week.
Report documentation to include: the adequacy qualifier, the absence of a transformation zone component, the ASC-US interpretation, the recommendation for reflex HPV and the specific follow-up intervals tied to each result, and a note that colposcopy in pregnancy is performed without ECC or treatment. This converts a judgment call on a borderline slide into an auditable management plan.